Healthy Skepticism Library item: 17081
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Sargent C
Bayer’s Swiss Unit Will Appeal Price-Fixing Ruling (Update1)
Bloomberg.com 2010 Jan 19
http://www.bloomberg.com/apps/news?pid=20601100&sid=aIO423PNA6vo
Full text:
- Bayer AG’s Swiss unit, Bayer (Schweiz) AG, denied any involvement in fixing the price of its Levitra erectile dysfunction medicine and said it will appeal a ruling by the country’s competition commission.
“Bayer (Schweiz) didn’t make any agreements or have any discussions about the prices for the public with pharmacies or dispensing doctors,” the unit of Leverkusen, Germany-based Bayer said in an e-mailed statement today. “Bayer (Schweiz) is convinced that it operated within existing Swiss law.”
The Swiss Competition Commission fined local units of Bayer, Pfizer Inc. and Eli Lilly & Co. a total of 5.7 million Swiss francs ($5.6 million) for allegedly fixing the prices of erectile dysfunction medicines in the form of public price recommendations. Pfizer makes Viagra and Eli Lilly makes Cialis.
